114 related articles for article (PubMed ID: 15040072)
21. Hepatitis C virus infection and non-Hodgkin's lymphoma: a review and case report of nine patient.
Lizardi-Cervera J; Poo JL; Romero-Mora K; Castañeda B; Pichardo-Bahena R; Morán S; Uribe M
Ann Hepatol; 2006; 5(4):257-62. PubMed ID: 17151577
[TBL] [Abstract][Full Text] [Related]
22. Primary retroperitoneal non-Hodgkin lymphoma presenting with torturous generalized pruritus in an elderly.
Daponte A; Ioannou M; Gioti C; Kallitsaris A; Dalekos GN; Messinis IE
Arch Gynecol Obstet; 2007 Apr; 275(4):287-9. PubMed ID: 16947055
[TBL] [Abstract][Full Text] [Related]
23. Painless, rapidly increasing maxillary swelling and erythematous mucosa: differential diagnosis and therapy.
Rullo R; Addabbo F; Festa VM
J Can Dent Assoc; 2012; 78():c50. PubMed ID: 22673215
[No Abstract] [Full Text] [Related]
24. [Prognostic factors of invasive non-Hodgkin's lymphoma].
Yu H; Hong XN; Li J; Peng LP; Ye L
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):461-3. PubMed ID: 17974284
[TBL] [Abstract][Full Text] [Related]
25. Necrotizing leukoencephalopathy following CHOP chemotherapy.
Blaes AH; Santa-Cruz KS; Lee CK; Hui SK; Peterson BA
Leuk Res; 2008 Oct; 32(10):1611-4. PubMed ID: 18378307
[TBL] [Abstract][Full Text] [Related]
26. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
[TBL] [Abstract][Full Text] [Related]
27. New concepts in treatment approaches and prognostic factors in aggressive NHL.
Shipp M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):107-9. PubMed ID: 16728917
[No Abstract] [Full Text] [Related]
28. Primary gastric lymphoma.
Parvez T; Behani A; Ali A
J Coll Physicians Surg Pak; 2007 Jan; 17(1):36-40. PubMed ID: 17204218
[TBL] [Abstract][Full Text] [Related]
29. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
30. Non-Hodgkin's lymphomas.
Theodossiou C; Schwarzenberger P
Clin Obstet Gynecol; 2002 Sep; 45(3):820-9. PubMed ID: 12370624
[No Abstract] [Full Text] [Related]
31. Relapsed non-Hodgkin lymphoma in fraternal twins managed successfully with rituximab maintenance therapy.
Chakravarti A; Leslie WT; Venugopal P
Clin Adv Hematol Oncol; 2005 Feb; 3(2):136-9; discussion 139-40. PubMed ID: 16166983
[No Abstract] [Full Text] [Related]
32. Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin's lymphoma.
Pedersen LM; Klausen TW; Davidsen UH; Johnsen HE
Ann Hematol; 2005 Aug; 84(8):510-6. PubMed ID: 15834569
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte.
Mounier N; Gisselbrecht C; Brière J; Haioun C; Feugier P; Offner F; Recher C; Stamatoullas A; Morschhauser F; Macro M; Thieblemont C; Sonet A; Fabiani B; Reyes F;
J Clin Oncol; 2004 Jul; 22(14):2826-34. PubMed ID: 15254050
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study.
Bernard M; Cartron G; Rachieru P; LeMevel A; Branger B; Le Maignan C; Berthou C; Ghandour C; Delwail V; Milpied N; Cassasus P; Celigny PS; Guyotat D; Lamy T; Desablens B;
Haematologica; 2005 Jun; 90(6):802-9. PubMed ID: 15951293
[TBL] [Abstract][Full Text] [Related]
35. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
[TBL] [Abstract][Full Text] [Related]
36. [Bilateral primary non-Hodgkin's lymphomas of the adrenals].
Rezgui-Marhoul L; Bouslama K; Bouchriha M; Harmel A; Mzabi-Rgaya S; Hendaoui L; Ben Dridi M
Ann Med Interne (Paris); 2003 Dec; 154(8):549-51. PubMed ID: 15037833
[TBL] [Abstract][Full Text] [Related]
37. Complete regression of cardiac non-Hodgkin lymphoma.
Morillas P; Quiles J; Nuñez D; Senent C; Martínez S; Fernández JA; Bertomeu V
Int J Cardiol; 2006 Jan; 106(3):426-7. PubMed ID: 16337063
[No Abstract] [Full Text] [Related]
38. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
39. Classification updates and clinical investigations in indolent non-Hodgkin lymphoma.
Cheson BD
Clin Adv Hematol Oncol; 2008 Sep; 6(9):4-6. PubMed ID: 18998258
[No Abstract] [Full Text] [Related]
40. [Primary malignant non-Hodgkin's lymphoma of the heart].
Iwuagwu OC; Kober R
Rofo; 2002 Dec; 174(12):1578-9. PubMed ID: 12471533
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
